Myla Lai-Goldman

Dr. Lai-Goldman is chair and co-founder of GeneCentric Therapeutics since 2021. She also is a venture partner with Hatteras Venture Partners and managing partner of Personalized Science LLC. She spent more than 18 years at Laboratory Corporation of America Holdings (LabCorp), the last 10 years as executive vice president, chief medical officer and chief scientific officer. She currently serves on the boards of West Pharmaceutical Services, Akoya Biosciences, Qvella Corporation, and NovoPath.